Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
30.31
+0.90 (3.06%)
Nov 9, 2026, 11:22 AM EST - Market open
Agios Pharmaceuticals Employees
As of December 31, 2025, Agios Pharmaceuticals had 540 total employees, including 539 full-time and 1 part-time employees. The number of employees increased by 52 or 10.66% compared to the previous year. That makes Agios Pharmaceuticals the 19,481st largest employer in the world and 2,620th in the United States.
Employees
540
Change (1Y)
52
Growth (1Y)
10.66%
Revenue / Employee
$260,820
Profits / Employee
-$690,552
Market Cap
1.81B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 540 | 52 | 10.66% | 539 | 1 |
| Dec 31, 2024 | 488 | 102 | 26.42% | 486 | 2 |
| Dec 31, 2023 | 386 | -7 | -1.78% | 383 | 3 |
| Dec 31, 2022 | 393 | 1 | 0.26% | 389 | 4 |
| Dec 31, 2021 | 392 | -170 | -30.25% | 390 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Nurix Therapeutics | 317 |
| Stoke Therapeutics | 170 |
| Zenas BioPharma | 167 |
| Maze Therapeutics | 141 |
| Absci | 140 |
| Mesoblast | 108 |
| Lycia Therapeutics | 31 |
AGIO News
- 3 days ago - Agios Pharmaceuticals price target lowered to $48 from $50 at BofA - TheFly
- 3 days ago - Agios Pharmaceuticals price target raised to $62 from $55 at H.C. Wainwright - TheFly
- 3 days ago - Agios Pharmaceuticals price target lowered to $35 from $37 at Truist - TheFly
- 4 days ago - Agios Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 4 days ago - Agios Pharmaceuticals Earnings release: Q3 2026 - Filings
- 4 days ago - Agios Pharmaceuticals Slides: Q3 2026 - Filings
- 4 days ago - Agios Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 4 days ago - Agios Pharmaceuticals reports Q3 EPS ($1.09), consensus ($1.23) - TheFly